Isotopes for isotopically labeling proteins for solution Nuclear Magnetic Resonance (NMR) investigation
Closed Solicitation Posted
- Solicitation number
- 75N94025Q00198
- Agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, through the Eunice Kennedy Shriver National Institute of Child Health and Human Development on behalf of the National Institute of Diabetes and Digestive and Kidney Diseases, is procuring specialized isotopes for isotopically labeling proteins for Nuclear Magnetic Resonance (NMR) investigation. The required isotopes include 13C-glucose (100 grams), deuterated glucose (100 grams), 13C/deuterated glucose (100 grams), and 15N ammonium chloride (500 grams), each with specific packaging requirements. This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures as a Request for Quotation (RFQ) for commercial products, with vendors evaluated on their capabilities to provide products meeting the specified technical requirements. The solicitation follows streamlined procedures under FAR 12.6 and incorporates all applicable provisions and clauses through Federal Acquisition Circular 2025-04. Quotations are due by August 29, 2025, at 10:00 AM EST, with no separate written solicitation to be issued as this combined synopsis serves as the complete solicitation document.
This procurement is not set aside for small businesses and will be awarded through full and open competition under the NAICS code 325412 (Pharmaceutical Preparation Manufacturing) with a size standard of 1,300 employees. No incumbent contractors or potential award values are specified in the available documentation. Delivery is required by October 2025 or within 30 days of contract award, with shipment to the NIH NIDDK facility in Rockville, Maryland. The contract will be structured as a Firm Fixed Price purchase order with payment made in one lump sum upon delivery and acceptance. The government reserves the right to reject any quotes that are non-compliant or fail to meet the solicitation's technical specifications, and vendors must ensure their products meet all specified isotope purity and packaging requirements. Performance will take place within the United States, specifically at the designated NIH facility location.
Notice text
This is a combined synopsis/solicitation for commercial products or services prepared in accordance with the format in FAR 12.6 (Streamlined Procedures for Evaluation and Solicitation for commercial items) as applicable, and as supplemented with additional information included in this notice. This acquisition will be processed in accordance with FAR Part 13 – Simplified Acquisition Procedures (SAP) for Certain Commercial Products and Services. This announcement constitutes the solicitation; quotes are being requested and a separate written solicitation will not be issued. This solicitation number is 75N94025Q00198 and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2025-04 (May 12, 2025).
The North American Industry Classification (NAICS) Code is 325412 and the business size standard is 1,300 employees.
This solicitation is NOT set aside for total small businesses.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) on behalf of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to award a Firm Fixed Price (FFP) purchase order through full and open competition to fulfill this requirement.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| CSS - Upgrading PExA 2.1 to Vial-Based (PExA Cap) | Office of Logisitics and Acquisition Operations | No set-aside | |
| NCSS - Bioruptor Pico Sonication Device | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| Clinical Research Support and Collaboration for NHGRI Protocols | Office of Logisitics and Acquisition Operations | Total Small Business | |
| NOI - 4D-Nucleofector Core Unit and X Unit | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity